Algiamed Technologies USA Inc

Algiamed Technologies develops the Stimpod NMS460, a non-invasive transcutaneous pulsed radiofrequency (tPRF) nerve therapy system designed to treat chronic pain, post-surgical pain, post-traumatic pain, and neuropathic conditions. The device uses electromagnetic therapy to restore natural nerve functionality by delivering brief bursts of radiofrequency stimulation through a handheld probe applied to the skin. The waveform travels along peripheral nerves to the dorsal root ganglion, recharging mitochondria and restoring intra-neural communication pathways. FDA-cleared and CE-certified, the Stimpod targets the biological root cause of pain conditions affecting the nervous system's homeostatic control mechanisms. The company serves chiropractors, physical therapists, pain management specialists, and medical doctors globally, supported by clinical trials and comprehensive online training through Algiamed University.